BACKGROUND: Peripheral vascular resistance has a major impact on arterial blood pressure levels. Endothelial C-type natriuretic peptide (CNP) participates in the local regulation of vascular tone, but the target cells remain controversial. The cGMP-producing guanylyl cyclase-B (GC-B) receptor for CNP is expressed in vascular smooth muscle cells (SMCs). However, whereas endothelial cell-specific CNP knockout mice are hypertensive, mice with deletion of GC-B in vascular SMCs have unaltered blood pressure.
L
arge population studies demonstrated a clear correlation between arterial blood pressure (BP) levels and cardiovascular risk. 1 The microcirculation determines, in a large part, the overall peripheral resistance and thereby arterial BP. 2 However, the factors and mechanisms regulating microcirculatory resistance are known only in part. 2 The atrial (ANP), B-type (BNP), and C-type (CNP) natriuretic peptides have crucial roles in the regulation of BP. 3 Even small variations in the human genes encoding ANP/ BNP or the pro-CNP convertase furin contribute to interindividual variations in BP and hypertension. [3] [4] [5] Cardiac ANP and BNP, via their shared cGMP-producing guanylyl cyclase-A (GC-A) receptor, coordinate renal function and endothelial permeability to maintain intravascular volume homeostasis. 6 In addition, these peptides counterregulate the various pressor actions of the renin-angiotensinaldosterone and sympathetic systems. 3 The third member of this peptide family, CNP, received its name because it shares a common amino acid core structure with previously isolated ANP and BNP. 3 However, human and murine genetic studies later revealed that CNP's major physiological function is not the regulation of renal natriuresis. Instead, CNP is most critical during bone development, stimulating physiological endochondral bone growth by autocrine activation of its specific cGMP-forming guanylyl cyclase-B (GC-B) receptor in chondrocytes. 7 Hence, inhibitory mutations of the genes encoding CNP (Nppc) or GC-B (Npr2) lead to severe dwarfism in humans and mice. 3, 7 In addition, CNP is constitutively released at low levels by endothelial cells, and mice with endothelialspecific CNP ablation are hypertensive. 8, 9 These and other studies indicated that CNP both complements and augments the homeostatic paracrine actions of endothelial nitric oxide in the local moderation of peripheral resistance and BP. 3 Indeed, the GC-B receptor is expressed in vascular endothelial and vascular smooth muscle (SMC) cells (VSMC) and exogenous, synthetic CNP exerted acute endothelium-dependent (nitric oxide-mediated) and -independent vasodilatatory effects on isolated macrovessels such as aortae and mesenteric arteries. [8] [9] [10] However, it is intriguing that mice with SMC-specific GC-B knockout (KO) have unaltered BP. 9 Together with pharmacological studies of synthetic agonists, these observations led to the concept that another receptor, the natriuretic peptide receptor-C (NPR-C), mediates the local vascular effects of CNP. 8, 10, 11 NPR-C was previously thought to act as an natriuretic peptide clearance receptor, because it does not signal via cGMP. Its intracellular region consists of only 37 amino acids forming overlapping G i/o -binding sequences that may trigger G-protein-linked processes. Indeed, CNP-dependent activation of NPR-C in cultured macrovascular SMCs causes hyperpolarization and relaxation. 3 However, mice with global NPR-C ablation have mild hypotension (not hypertension) and elevated natriuretic peptide levels, a phenotype that is consistent with the sole function of NPR-C being to clear natriuretic peptides. 11 Ultimately, the target cells and receptor signaling pathways of endothelial CNP remain unclear.
Here, we dissected the vasodilating response to CNP along the vascular tree. We found that the effect of CNP increases toward very small precapillary arterioles and capillaries, where pericytes gradually replace VSMCs. Because our cell culture studies revealed that both microcirculatory endothelial cells and pericytes express GC-B receptors, we applied the Cre/loxP system to dissect the role of microvascular endothelial versus mural, ie, pericyte GC-B/cGMP signaling in BP regulation by CNP. Our observations contribute to a better understanding of the vascular role of CNP, demonstrating that the endothelial hormone acts on neighboring pericytes to regulate microcirculatory resistance.
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. A detailed description of
Clinical Perspective
What Is New?
• Endothelial C-type natriuretic peptide (CNP) participates in the local moderation of vascular tone.
• Its cyclic GMP-synthesizing guanylyl cyclase-B receptor is expressed in several vascular cell types (such as endothelial cells, smooth muscle cells, and pericapillary pericytes), but exactly how it mediates the effects of CNP is unclear.
• This study uses novel gene-modified mouse models to show that guanylyl cyclase-B/cGMP signaling in pericytes diminishes microcirculatory resistance and arterial blood pressure, whereas endothelial or macrovascular smooth muscle cell guanylyl cyclase-B signaling is not involved.
• This indicates that CNP participates in a local cross talk between endothelial cells and pericytes.
What Are the Clinical Implications?
• The microcirculation determines in large part the overall peripheral resistance.
• Moreover, endothelial cell dysfunction and increased microvascular resistance are important determinants of essential arterial hypertension.
• It is conceivable that diminished endothelial CNP to pericyte guanylyl cyclase-B signaling participates in the pathophysiology of arterial hypertension.
• Based on our findings, pharmacological augmentation of endogenous CNP signaling in pericytes, for instance, by sacubitril/valsartan (LCZ696, which inhibits neprilysin-mediated CNP degradation), might provide a useful therapeutic tool to combat increased vascular resistance and hypertension.
Generation of Mice With Conditional, Cell-Restricted Deletion of GC-B
All animal studies complied with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication no. 85-23, revised 1996) and were approved by the local animal care committees. Details of the generation of mice with a floxed GC-B gene (Npr2
) are provided in the online-only Data Supplement (see Table I 
Generation of Mice With Inducible Expression of a cAMP-Fluorescence Resonance Energy Transfer Sensor in Pericytes
To generate conditional R26-STOP-Epac1-camps mice, the Epac1-camps fluorescence resonance energy transfer (FRET) sensor, 17 a woodchuck hepatitis virus posttranscriptional regulatory element and a poly(A) sequence were placed downstream of the transcriptional stop cassette 18, 19 ( Figure III in the online-only Data Supplement). Gene targeting in embryonic stem cells is described in the online-only Data Supplement. To remove the floxed STOP-cassette and thereby obtain conditional expression in pericytes, R26-STOP-Epac1-camps mice were mated with PDGFRβ-Cre-ERT2 mice. Tamoxifen induction was performed as above. FRET microscopy was done 3 weeks later in explanted live retinas (see below) for visualization of cAMP dynamics in single pericapillary pericytes in real time.
Intravital Microscopy of the Murine Cremaster or Retinal Microcirculation
Studies were conducted in wild-type C57Bl/6 mice, the heregenerated novel transgenic lines, and in NG2DsRedBAC reporter mice having fluorescent pericytes, as well (stock Tg(Cspg4-DsRed.T1)1Akik/J; The Jackson Laboratory 20 ). For studies of the cremaster muscle microcirculation, mice were anesthetized with intraperitoneal injections of ketamine (100 mg/kg body weight) and xylazine (10 mg/kg). 21 The depth of anesthesia was checked by ensuring that noxious pinch stimulation of the hind paw, the forepaw, and the ear did not evoke any motor reflexes. 21 The exteriorized cremaster was superfused with bicarbonate-buffered saline (pH 7.4, 34°C) with or without CNP and endothelin-1 (ET-1; both from Bachem). Proximal arterioles were observed by regular light microscopy. Distal precapillary arterioles and capillaries were visualized in separate experiments after tail vein injection of fluorescein isothiocyanate-labeled dextran (molecular weight 70 000 Da, 1 mg/mL, 100 µL, Sigma-Aldrich), using a fluorescence filter for fluorescein isothiocyanate for epi-illumination (Olympus).
For live imaging of fluorescein isothiocyanate-isolectin-B4-labeled retinal capillaries, eyes were removed from adult mice after euthanization under deep anesthesia (3% isoflurane). Dissected retinas were transferred to buffer (in mmol/L: 140 NaCl, 2.5 KCl, 1.8 CaCl 2 , 1.0 MgCl 2 , 20 HEPES, 20 d-glucose; pH 7.4, 34°C) and imaged as above. 22 Quantitative off-line analysis of the microscopic images was performed with the computer-assisted image analysis system Cell-D (Olympus). 21 Changes in vascular diameter were determined from 5 to 10 different segments per vessel. Such preselected segments were observed every 5 (retina) or 10 minutes (cremaster), and responses were calculated as percent change in diameter versus baseline. Changes of the body areas of single fluorescent pericapillary pericytes in response to ET-1 application were calculated as percent change versus baseline.
Culture of Microvascular Endothelial Cells and Pericytes, and of Macrovascular SMCs
To culture microvascular lung endothelial cells (MLECs), cortical pericytes and aortic VSMCs, lungs, brains, and aortae were dissected from adult mice after euthanization under deep anesthesia. MLEC cultures were described before. 6, 23 Cortices were incubated in 30 U/mL papain and 40 μg/mL DNase I (70 minutes at 37°C). The tissue digest was pelleted, resuspended in endothelial growth medium (CC-3202; Lonza Walkersville Inc), and plated on collagen-coated wells. Following the third passage, cells were maintained in pericyte medium (Provitro AG) containing 2% fetal bovine serum. 24 Immunocytochemistry with antibodies against the pericyte markers NG2 (Merck Chemicals GmbH) and PDGFRβ (platelet-derived growth factor receptor β; Bio-Techne) demonstrated that, after the fourth passage, ≈95% of cells were pericytes. Human dermal microvascular endothelial cells (C-12210) and placental pericytes (C-12980) were from PromoCell GmbH. Primary murine aortic VSMCs were isolated and cultured for 7 days.
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Studies of Intracellular cGMP and cAMP
Aortae from adult mice were dissected, cut in 5-mm-thick rings, and incubated in 1 mL buffer (in mmol/L: 140 NaCl, 2. Arterial BP levels were determined in awake mice by tail-cuff plethysmography 6 and radiotelemetry. 26 Telemetric recordings were performed with the Data Sciences International telemetry system. Transmitters (model TA11PA-C10) were implanted under sevoflurane anesthesia, with a 1-week recovery period before measurements. The telemeter catheter was inserted into the left carotid artery and advanced into the aortic arch, with the telemeter body positioned subcutaneously. Terminal simultaneous recordings of aortic (AoP) and central (jugular) venous pressures (CVP), heart rate, cardiac output (CO), and ejection fraction were performed under isoflurane (2%) anesthesia with Millar SPR-671 Mikro-Tip pressure and SPR-839 Mikro-Tip pressure-volume catheters. 23, 27 Total peripheral resistance (TPR, mm Hg/mL×min) was derived from the equation ΔBP (AoP -CVP) = CO × TPR.
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Ratiometric Fluorescence Measurements of Intracellular Ca
2+
Ca
2+ ratiometric fluorescence measurements in Fura 2-AMloaded pericytes were performed in Tyrode solution containing 1 mmol/L Ca 2+ as described. 29 Data were corrected for background 340/380 fluorescence and analyzed by using IonWizard 6.3 software (Ionoptix).
Statistics
Data are presented as means±SEM (with the number of experiments described in the figure legends). Statistical analysis was performed on experimental data consisting of 2 groups using an unpaired Student t test. A paired t test was used to evaluate the vascular effects of CNP and BNP in the muscle cremaster and in isolated perfused kidneys. Comparison of >2 groups was evaluated with 2-way ANOVA followed by unpaired Student t tests with the Bonferroni correction for multiple comparison. The interactions of CNP and ET-1 in the microcirculation of the cremaster muscle and retina, and the systolic arterial BP measurement data before and after tamoxifen, as well, were analyzed by repeated-measures ANOVA followed by the Bonferroni post hoc test. For all tests, a value of P<0.05 was considered statistically significant. Statistical analysis was performed with GraphPad Prism Software.
RESULTS
Vasodilatatory Effects of CNP Increase Toward the Microcirculation
The effects of CNP along the vascular tree were studied by intravital microscopy of the murine cremaster muscle microcirculation. Vessels were defined based on branching patterns as second-order arterioles (derived from the largest arteriole entering the cremaster; internal diameter [Ø], 50-80 µm); precapillary arterioles (Ø 8-13 µm) and capillaries (Ø 5-7 µm). 30 As shown in Figure 1A , topical application of CNP (100 nmol/L; 10-minute superfusion) had no effect on the resting diameter of proximal arterioles but significantly dilated precapillary arterioles and capillaries.
It is interesting to note that this pattern of CNP actions resembled the vasoconstrictory actions of ET-1, which are also greater in the microcirculation, ie, in capillaries. 31, 32 Increased release of this potent vasoconstrictor underlies the elevated vascular tone in diseases associated with endothelial dysfunction. 33, 34 However, ET-1 stimulates endothelial CNP release, 35 suggesting that under physiological conditions, ET-1 constriction could be self-limited by release of CNP. To follow this hypothesis, we studied the functional interactions between these peptides. In proximal arterioles, ET-1 (10 nmol/L, 5 minutes) caused a pronounced and stable constriction that was not reversed by CNP (100 nmol/L, 30 minutes) ( Figure 1B 
CNP Activates GC-B/cGMP Signaling in Microcirculatory Pericytes and Endothelial Cells
Based on the vasodilatatory actions of CNP in the microvasculature and its inhibitory effects on ET-1-evoked pericyte contractions, we studied GC-B/cGMP signaling in microcirculatory endothelial cells and pericytes. CNP concentration dependently increased the intracellular cGMP levels of cultured human and murine endothelia and pericytes (Figure 2A and 2B) . As also shown, in endothelial cells, the cGMP responses to CNP were milder than the responses to ANP; conversely, in pericytes, CNP had greater effects. Accordingly, in pericytes CNP and ANP led to activation of cGMP-dependent protein kinase I (cGKI) and thereby to phosphorylation of the cytoskeleton-associated vasodilator-stimulated
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phosphoprotein at Ser 239 ( Figure 2C ). We conclude that microvascular endothelial cells and pericytes express the GC-A and GC-B receptors for natriuretic peptides. In endothelial cells, ANP/GC-A signaling prevails, whereas pericyte cGMP levels are mainly stimulated by the CNP/GC-B pathway. A, Intravital microscopy studies of the murine cremaster muscle microcirculation revealed that CNP (100 nmol/L, topical application) did not dilate proximal arterioles (n=8 mice), but significantly dilated precapillary arterioles and capillaries (n=5 mice). Images of these fine distal vessels were enhanced by injection of FITClabeled dextran (Top). B, Topical application of ET-1 (5 minutes superfusion of 10 nmol/L for studies of proximal arterioles (n=8 mice per condition); 0.1 nmol/L for distal vessels (n=5 per condition) caused strong and stable vasoconstrictions. Only in precapillary arterioles and capillaries these constrictions were reversed by CNP (100 nmol/L). Top, Original images revealing that ET-1 caused almost complete closure of fine arterioles and capillaries, which was fully reversed by CNP. C, Images of fluorescent pericytes were captured in cremaster muscle capillaries of NG2DsRedBAC reporter mice with a 63× water-immersion objective. 
Generation of Novel Genetic Mouse Models With Pericyte-or EndotheliumRestricted Deletion of the GC-B Receptor
To dissect the role of GC-B signaling in the microcirculation in vivo, we generated mice with cell-targeted deletions of this receptor using Cre/LoxP technology. We floxed exon 7 of the GC-B-encoding Npr2 gene because the deletion of this exon results in a frame shift and premature stop codon ( Figure 3A) . Npr2 flox/flox mice were viable and fertile, and they exhibited no noticeable phenotypic changes. Crossings of these mice to Pgk-1 Cre TG mice with early and uniform Cre expression 12 fully abolished GC-B protein expression ( Figure 3B ) and provoked severe dwarfism. Nasoanal and tibia lengths of 10-week-old Pgk-1 Cre; Npr2 flox/flox mice were 29% and 43% shorter than to Npr2 flox/flox littermates ( Figure 3C ). This recapitulates the phenotype previously reported for mice with global, constitutive GC-B deletion 36 and demonstrates efficient Cre-mediated recombination and disruption of the Npr2 flox/flox gene. Npr2 flox/flox mice were then crossed with Tie2-Cre mice (for endothelial GC-B ablation 6, 13 ) or with recently generated transgenic mice expressing CreER T2 recom- 
Microcirculatory Vasodilating Effects of CNP Are Endothelium Independent and Mediated by Pericytes
To dissect the contribution of endothelial cells versus pericytes to the microcirculatory effects of CNP, we performed intravital microscopy studies in EC GC-B KO and pericyte GC-B KO mice. The direct vasodilatatory effects of CNP on precapillary arterioles and capillaries were unaltered in the cremaster muscle of EC GC-B KO mice but abolished in pericyte GC-B KO animals ( Figure 5A ). Moreover, the counterregulatory effects of CNP on ET-1-induced arteriolar and capillary constrictions were fully preserved in EC GC-B KO mice but absent in pericyte GC-B KO mice ( Figure 5B) . 
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In principle, the changes in capillary luminal diameters during exposure to ET-1 and CNP could reflect passive responses to changes in intravascular pressure resulting from upstream constriction/dilatation of the precapillary arterioles. To exclude this possibility, we performed complementary studies in explanted murine retinas. Such preparations are disconnected from the circulation and therefore lack active pressure-dependent blood flow, but remain viable for ≈2 hours. 22 In comparison with the cremaster, ET-1 (0.1 nmol/L)-induced constrictions of retinal capillaries were milder but equally consistent ( Figure 5C ). In control retinas (prepared from Npr2 flox/flox mice with/ without tamoxifen treatment), addition of CNP (100 nmol/L) fully reversed this effect ( Figure 5C ). Such CNP-induced dilatations of retinal capillaries were unaltered in EC GC-B KO ( Figure 5C , left) but abolished in pericyte GC-B KO mice ( Figure 5C , Right). Superfusion of the adenosine A2A receptor agonist CGS-21680 (100 nmol/L) provoked complete capillary dilatations in the later genotype, proving viability. Together, these observations demonstrate that the inhibitory effects of CNP on the microcirculatory tone are endothelium independent and mediated by GC-B/cGMP signaling in the SMCs of distal arterioles and capillary pericytes.
Mice With Pericyte Deletion of GC-B Have Elevated Arterial BP Levels Despite Preserved Renal Function and Suppressed Renin
To address the role of pericyte GC-B signaling in the regulation of arterial BP, PDGFRβ-CreER T2 -positive and -negative Npr2 flox/flox littermates were subjected to measurements by tail cuff and telemetry. Under baseline conditions, mean BP did not differ between genotypes and sexes ( Figure 6A) . Activation of the Cre TG with tamoxifen caused a significant, sex-independent and sustained increase in BP in the PDGFRβ-CreER T2 -positive (pericyte GC-B KO) cohort ( Figure 6A ). The PDGFRβ-CreER T2 -negative controls exhibited no change in BP on tamoxifen treatment, ruling out a Cre-independent effect of tamoxifen (Figure 6A ). An effect of activated PDGFRβ-CreER T2 was excluded by monitoring BP in tamoxifen-induced mice carrying the Cre TG on a wild-type background (not shown). Telemetric recordings and invasive hemody- 
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namics confirmed that pericyte GC-B KO mice have mild but very consistent arterial hypertension during both the light and dark portions of their day, together with enhanced total peripheral resistance ( Figure 6B and 6C). Heart rate, spontaneous locomotor activity ( Figure 6B ), and cardiac contractile parameters such as cardiac output and ejection fraction were not different between genotypes ( Figure 6C ). These results indicate that endogenous pericyte CNP/GC-B signaling is involved in the chronic regulation of microcirculatory resistance and BP. It is important to note that the hypertensive effect of pericyte GC-B disruption persisted throughout age (BP was monitored by tailcuff up to 6 months after tamoxifen induction and remained stably elevated; Figure 6A ). Pericytes have important roles in the kidney, such as regulation of medullary blood flow. 32 It was also suggested that renin-producing cells derive from pericytes. 37 Therefore, we addressed the possibility that hypertension of pericyte GC-B KO mice originates from changes in renal perfusion, excretory function, or renin activity. However, experiments with isolated perfused kidneys (ex situ) clearly demonstrated that CNP (1-100 nmol/L), in contrast to BNP, had no effect on renal perfusion flow and vascular resistance ( Figure 
In Pericytes, CNP/GC-B Signaling Stimulates a Positive cGMP-to-cAMP Cross Talk and Moderates Calcium Responses to Endothelin
Immunoblotting showed that pericytes not only express cGKI but also the cGMP-inhibited cAMP-degrading PDE3A ( Figure 7A ). To study whether CNP/GC-B/cGMP signaling in pericytes modulates cGKI and PDE3A activity, we studied the phosphorylation of vasodilator- A, Blood pressure was measured by tail-cuff in PDGFRβ-CreER T2 -positive and -negative Npr2 flox/flox mice before and 2 weeks and 6 months after treatment with tamoxifen. Induction with tamoxifen caused a significant and stable increase in systemic blood pressure in male and female mice of the Cre + cohort (pericyte GC-B KO mice) (n=8 mice per genotype). B, The hypertensive phenotype of pericyte GC-B KO mice was confirmed by telemetric recordings in ≈3-month-old mice. Heart rate and locomotor activity did not differ between genotypes (n=8). C, Invasive hemodynamic measurements showed increased arterial blood pressure and total peripheral resistance in pericyte GC-B KO mice. Cardiac output and ejection fraction were not different between genotypes (n=9). *P<0.05, significantly different from baseline; #P<0.05, significantly different from corresponding Npr2 flox/flox littermates (controls). A.U. indicates arbitrary units; BP, blood pressure; CNP, C-type natriuretic peptide; GC-B, guanylyl cyclase-B; KO, knockout; P, pressure; and SMC, smooth muscle cell.
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stimulated phosphoprotein at Ser 239 (the cGKI-specific site) and at Ser 157 (the cAMP/PKA-specific site). In control pericytes, CNP enhanced phosphorylations of vasodilator-stimulated phosphoprotein at both sites; these effects were abolished in GC-B-deficient pericytes (Figure 7B ; quantitation in lower panels). We conclude that CNP/GC-B/cGMP signaling modulates both cGKI and PDE3A activities in pericytes. FRET microscopy is an elegant approach for the visualization of cAMP dynamics in living cells in real time. To analyze PDE3A-mediated effects of CNP on cAMP levels, we generated a novel genetic mouse model expressing the cAMP FRET-sensor Epac1-camps 17 selectively in pericytes. Single-cell cAMP responses were recorded in cultured pericytes and in retinal capillary pericytes in situ. The FRET responses to 100 nmol/L CNP were calculated as percentage of the effect caused by subsequent addition of forskolin with 3-isobutyl-1-methylxanthine, which fully activates this sensor (FRET in % of maximum 17 ). Figure 8A (left and middle) depicts original tracings showing that CNP clearly elevated cAMP levels in cultured or native pericytes, the effect being ≈30% of maximum ( Figure 8A, right) . Inhibition of PDE3 with 10 µmol/L cilostamide mimicked the effect of CNP on retinal pericytes and subsequent superfusion of CNP had no additional effect ( Figure 8A, right) .
The contractile activity of pericytes is controlled by changes of cytosolic free Ca 2+ concentration. 38 To study whether CNP, via GC-B, influences the Ca 2+ responses of pericytes to ET-1, last, we performed ratiometric recordings in Fura-2-loaded cultured pericytes. ET-1 (0.1 nmol/L) evoked sudden rises in [Ca 2+ ] i ( Figure 8B ). In control pericytes, CNP (100 nmol/L) pretreatment fully prevented this Ca 2+ response. In GC-B-deficient pericytes, the Ca 2+ signals induced by ET-1 were unaltered; however, the inhibitory effect of CNP was fully abolished ( Figure 8B ).
DISCUSSION
Endothelial CNP is involved in the regulation of BP, but the target cells and intracellular signaling pathways were unclear (see review 3 ). Our studies show that the vasodilatatory effects of CNP predominate in precapillary arterioles and capillaries, where pericytes gradually replace VSMC. Disruption of the GC-B receptor under the control of the PDGFRβ promoter abolished CNP/ GC-B/cGMP signaling in pericytes and increased arterial BP. We propose that CNP participates in the paracrine communication between endothelial cells and pericytes, thereby moderating peripheral vascular resistance and arterial BP.
In contrast to the endocrine cardiac hormones ANP and BNP, CNP is barely detectable in blood plasma. 8, 9 CNP and its GC-B receptor exert local, auto/paracrine functions in many different tissues, especially in bone development and reproduction. 3 Within the cardiovascular system, CNP is constitutively released by endothelial cells. 3, 8 Synthetic CNP causes vasodilatation of isolated arteries and lowers BP, although with lower potency than ANP. 39 Therefore, CNP is conceived as the vascular, paracrine BP-regulating member of the NP family. Indeed, recent mouse genetic studies demonstrated that endogenous endothelial CNP participates in the physiological maintenance of chronic arterial BP homeostasis. 8, 9 It is notable that, based on studies with synthetic agonists, the vasodilating actions of CNP were considered to be independent of GC-B but mediated by ORIGINAL RESEARCH ARTICLE NPR-C, a receptor lacking the cGMP-synthesizing GC domain. 8 In cultured VSMCs, NPR-C may couple to G i proteins and activate a G-protein-linked inwardly rectifying potassium channel (GirK). Because K + efflux hyperpolarizes the cell and this can elicit a vasorelaxation response, CNP was considered as an endothelium-derived hyperpolarizing factor. 40 However, endotheliumderived hyperpolarizing factor activity is preserved in the mesenteric arteries of mice with global deletion of NPR-C. 41 Moreover, these mice have mild hypotension and elevated natriuretic peptide levels, which is consistent with the function of NPR-C being to clear ANP, BNP, and CNP.
11 Indeed, the NPR-C binds all 3 natriuretic peptides, the affinity of ANP being ≈10-fold higher than the affinity of CNP. 42 It seems difficult to reconcile that the vasorelaxing and hypotensive effects of CNP are mediated by NPR-C, 8 whereas the vasorelaxing and hypotensive effects of ANP are fully mediated by GC-A. 39 Supporting the view that CNP signals via NPR-C, in another study, the GC-B receptor was depleted from VSMC by crossing floxed GC-B mice with SM22-Cre mice, and the resultant SMC GC-B KO mice had unaltered BP. 9 However, SM22-driven Cre recombinase causes only a patchy deletion of floxed target genes in larger arteries such as the aorta, mesenteric artery, and main lung arteries, 43 which only marginally contribute to peripheral resistance.
Because the overall peripheral resistance is mainly determined by small arterioles with diameters of ≤50 µm, 2 we studied the effects of CNP in the microcirculation of the cremaster muscle and retina. The cremaster muscle is representative of the skeletal muscle, which recruits ≈20% of cardiac output during rest and up to 80% during exercise, and thereby significantly contributes to overall vascular resistance. 2, 44 The studies of retinal capillaries had the advantage that, in this flow-free system, responses of capillaries are independent of the upstream arterioles. We found that CNP barely affects the tone of proximal arterioles, but markedly dilates the small precapillary arterioles and capillaries with diameters of <15 µm. Compatible with a prominent role of CNP in the microcirculation, exogenous CNP counterregulated the vasoconstrictory effects of ET-1 specifically in such terminal vascular beds. Whereas the endothelium of arteries and larger arterioles is fully covered by several layers of adjacent VSMCs, in smaller vessels they 
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become gradually replaced by a very distinct cell type, the pericyte. Pericytes are spatially isolated contractile cells embedded within the endothelial basement membrane of precapillary arterioles, capillaries, and small postcapillary venules. 45, 46 They can be identified by their unique bump-on-a-log morphology and by expression of the growth factor receptor PDGFRβ and its coreceptor, the proteoglycan NG2. 45, 46 They have multiple thin cytoplasmic processes encircling the endothelial cells, with which they maintain an intimate cross talk, both through direct interaction and via paracrine factors. This communication is essential for the control of microcirculatory resistance and blood flow. [44] [45] [46] Our experiments with cultured microvascular endothelial cells and pericytes revealed that CNP, via GC-B, regulates intracellular cGMP levels in both cell types. However, deletion of GC-B in endothelial cells did not alter the dilating effects of CNP in the microvasculature. In contrast, deletion of GC-B in pericytes abolished this effect of CNP and provoked chronic increases in peripheral resistance and arterial BP. Accordingly, microscopy studies in reporter mice with fluorescent pericytes illustrated that the arteriolar and capillary dilating effects of CNP occur at pericyte sites and that CNP prevents ET-1-induced pericyte contractions. Together these results indicate that CNP participates in the local, paracrine communication between endothelial cells and pericytes, and thereby in chronic BP regulation. They also provide insights into the antagonistic relation between the vasoconstrictory ET-1 and the vasodilatory CNP pathways in the microcirculation. Imbalance between these pathways may contribute to the enhanced peripheral resistance of pericyte GC-B KO mice, although this was not directly tested in this study. The average increases of BP in pericyte GC-B KO (present study) and endothelial CNP KO mice 8, 9 were very similar (Δsystolic BP≈12-15 mm Hg), suggesting that pericytes mediate, in a large part, the BP-moderating effects of endothelial CNP.
It is notable that the pericyte GC-B KO mice had sustained increases in arterial BP despite unaltered renal excretory function. Our observations strengthen the emerging concept that the regulation of peripheral microvascular tone is critically involved in the longterm control of systemic BP. 44, 47 This concept is supported by observations in other genetic mouse models in which endothelial or VSMC disruption of relevant genes (RGS2, GC-A, aldosterone receptor) altered BP levels without any defects in renal sodium/water excretion. 6, 47, 48 In fact, although CNP and GC-B are indeed expressed at low levels in the kidney, studies with exogenous, synthetic CNP only revealed small natriuretic or even antinatriuretic effects, 3 and no effects on renal perfusion flow and vascular resistance (present study). Moreover, our observation that plasma renin levels were not enhanced but markedly reduced in the conditional pericyte GC-B KO mice also argues against a major role of the kidney in the hypertensive effect of microvascular GC-B disruption. Suppressed renin might be a compensatory response preventing further increases in BP.
The contractile activity of pericytes is controlled by changes of cytosolic Ca 2+ and cAMP. 38, 49 In particular, it was shown that ET-1 induces a long-lasting Ca 2+ spike activating a strong and prolonged contraction of pericytes. Subsequent pericyte relaxation is so slow that, even after complete restoration of the intracellular Ca 2+ level, pericyte relaxation is delayed for 30 minutes. 50 In line with these studies, we observed that ET-1 provoked transient raises of pericyte Ca 2+ levels (in vitro) and strong and stable contractions of pericapillary pericytes in the musculus cremaster (in vivo). It is notable that CNP prevented the effects of ET-1 on pericyte Ca 2+ (in vitro) and contraction (in vivo). Our studies with cultured pericytes indicate that CNP/GC-B signaling, via cGMP, modulates the activity of 2 downstream calcium and contraction-regulating messengers: cGKI, which can phosphorylate IRAG (inositol 1,4,5-trisphosphate receptor I-associated protein) and thereby prevent ET-1-induced inositol triphosphate-mediated calcium release from intracellular stores 38 ; and PDE3A, a cGMPinhibited PDE that mediates a positive cGMP-cAMP cross talk. 3 Enhanced cAMP levels and activation of PKA may lead to decreased phosphorylation of contractile proteins such as myosin light chain causing pericyte relaxation. 49 The role of PDE3A is supported by FRET experiments with explanted murine retinas, showing that CNP elevates cAMP levels of native pericytes surrounding retinal capillaries.
CONCLUSIONS
Our studies indicate that endothelial paracrine CNP activates GC-B/cGMP signaling in microcirculatory pericytes and thereby lowers peripheral vascular resistance and arterial BP. A positive CNP/GC-B-stimulated cross talk of cGMP to cAMP within pericytes plays a key role in the chronic regulation of BP. Our observations provide novel insights into the role of natriuretic peptides in the vascular system and underlying mechanisms.
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